This week the London Mayor’s race erupted around a question that is bound to delight drug reformers – cannabis reform in the capital. Whilst the naysayers are crying electoral point-scoring on both sides across the echo chambers of Twitter, groups like Volteface have been busy behind the scenes engineering an environment that is ripe … Continued
In the latest edition of the Volteface podcast Paul charts with Dr. Giulia Zampini about the recently launched People and Dancefloors research project and have a heated discussion on why drug reform needs a shake up to better engage public, policy makers and politicians. To find out more about People and Dancefloors, please click … Continued
In Volteface’s first documentary, Director Paul North takes a trip to Brighton to catch up with Carly Barton, who was the first patient to legally receive medical cannabis in the UK, to discuss the new Cancard scheme. The Cancard scheme is a medical cannabis scheme that is devised with doctors, police and patients. Under … Continued
Belgium, June 2019: I am convicted along with nineteen other pioneers, based on the 1921 drug law. As a doctor in medical science, researcher, nurse and former humanitarian aid worker, I am all of a sudden demoted to an ordinary criminal, convicted to fifteen months in prison for my volunteering in an Antwerp Cannabis … Continued
Today both Democrat candidates in the Georgian Senate runoff won their battles against their Republican counterparts, meaning that for the first time since 2006, the Democrats have control of both the House of Representatives and the Senate – a monumental feat, but what does this mean for cannabis? US States have been passing legalisation … Continued
Yesterday, history was made with the UN reclassifying cannabis. This removes cannabis from the list of most dangerous narcotics, recognising its medical value. The decision was voted on by the Commission for Narcotic Drugs. A series of recommendations on reclassifying cannabis were considered, the key being the removal of it from Schedule IV of … Continued
There are estimated to be 1.4 million patients in the UK who are eligible for a medical cannabis prescription. However, 73% of these patients are unable to afford one. As it stands there is a risk that patients who are experiencing difficulties in accessing medical cannabis could be criminalised. Today the Cancard scheme has … Continued
Volteface is delighted to announce our new video series All Good Points, a Volteface Production in partnership with Hanway Associates. We will be providing you with a 30 minute weekly discussions focused on global updates in the cannabis world, in a relaxed and conversational format and filmed in our central London studio. In the first … Continued
Last night, the United States voted on several initiatives for drug reform. Results hold overwhelming amounts of positive news, spanning from cannabis to psilocybin therapy. This is a pivotal and historic step toward ending the war on drugs. In Arizona 59.85% voted in favour of legalising cannabis. As a result of 50 years of … Continued
First Wednesdays, the network for entrepreneurs and investors in the European cannabis sector, today launched their much vaunted ‘European medical cannabis ecosystem’ providing expert insights and detailing marked developments into the European cannabis sector over the past decade. The report makes for positive reading for anyone interested in the developments of the medical cannabis … Continued